Akèy › Kansè Utèrin › Rhode Island › Providence

Etid klinik pou Kansè Utèrin nan Providence, RI

4 etid pou Kansè Utèrin ap chèche patisipan nan sit nan ak bò kote Providence (nan yon distans apeprè 30 mil). Louvri yon etid pou wè ki moun ki ka patisipe ak kijan pou kontakte ekip etid la.

Tèks ofisyèl etid la (Anglè)

Ap chèche patisipan pou yon etid? Mete l anwo paj sa a — $99 pou 30 jou →

Ocular Assessments in Patients Treated With Tivdak® in Recurrent or Metastatic Cervical Cancer

Ap rekriteFaz 4

Women & Infants Hospital of Rhode Island/The Program in Women´s Oncology - Clinic, Providence
Women & Infants Hospital of Rhode Island, Providence
Women & Infant´s Hospital Infusion Center, Providence

Laj 18 ak plis · Fanm · Mizajou Sep 25, 2026 · NCT06952660

DESTINY-Endometrial01: A Phase III Study of Trastuzumab Deruxtecan Plus Rilvegostomig or Pembrolizumab as First-Line Treatment of HER2-Expressing (IHC 3+/2+), Mismatch Repair Proficient (pMMR) Endometrial Cancer

Ap rekriteFaz 3

Research Site, Providence

Laj 18 ak plis · Fanm · Mizajou Sep 3, 2026 · NCT06989112

Rinatabart Sesutecan (Rina-S, PRO1184, GEN1184) for Advanced Solid Tumors (GCT1184-01/ PRO1184-001)

Ap rekriteFaz 1/2

Women and Infants Hospital of Rhode Island, Providence

Laj 18 ak plis · Tout sèks · Mizajou Aug 4, 2026 · NCT05579366

A Study to Assess the Efficacy and Safety of FORE8394 in Participants With Cancer Harboring BRAF Alterations

Ap rekriteFaz 2

Lifespan Cancer Institute - Rhode Island Hospital, Providence

Laj 8 ak plis · Tout sèks · Mizajou Jul 27, 2026 · NCT05503797

Etid Kansè Utèrin nan lòt vil

Lòt etid nan Providence

Sous ClinicalTrials.gov, done yo ranmase Oct 5, 2026. Chak etid gen kritè li pou li menm; ekip etid la deside ki moun ki ka patisipe.